Ignite Creation Date:
2024-05-05 @ 10:24 PM
Last Modification Date:
2024-10-26 @ 10:18 AM
Study NCT ID:
NCT01106027
Status:
TERMINATED
Last Update Posted:
2018-01-31
First Post:
2010-03-29
Brief Title:
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Organization Data
Organization:
Mayo Clinic
Class:
OTHER
Study ID:
09-005627DD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mayo Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
Mark Stegall
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Mayo Clinic
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Alexion Pharmaceuticals Inc | INDUSTRY |